157 related articles for article (PubMed ID: 2494164)
1. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
Nakano T; Hanasaki K; Arita H
J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation by tetraprenol via stimulation of phospholipase A2 action.
Nakano T; Matsumoto S; Hanasaki K; Arita H
J Biochem; 1989 Nov; 106(5):887-93. PubMed ID: 2533198
[TBL] [Abstract][Full Text] [Related]
3. Retinol induces platelet aggregation via activation of phospholipase A2.
Nakano T; Hanasaki K; Matsumoto S; Arita H
Biochem Biophys Res Commun; 1988 Aug; 154(3):1075-80. PubMed ID: 3408485
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction in collagen-stimulated rat platelets is composed of three stages.
Nakano T; Terawaki A; Arita H
J Biochem; 1987 May; 101(5):1169-80. PubMed ID: 3115969
[TBL] [Abstract][Full Text] [Related]
6. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
8. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets.
Murthy M; Rao GH; Robinson P; Reddy S
Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):31-9. PubMed ID: 7675820
[TBL] [Abstract][Full Text] [Related]
9. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets.
Hanasaki K; Nakano T; Arita H
Thromb Res; 1987 May; 46(3):425-36. PubMed ID: 2955543
[TBL] [Abstract][Full Text] [Related]
10. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
Faili A; Emadi S; Vargaftig BB; Hatmi M
Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
[TBL] [Abstract][Full Text] [Related]
12. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
13. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP
Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246
[TBL] [Abstract][Full Text] [Related]
14. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
15. Increased cytosolic phospholipase A2 activity is not accompanied by arachidonic acid liberation in U46619-stimulated rabbit platelets.
Akiba S; Abe T; Sato T
Biochem Mol Biol Int; 1995 Feb; 35(2):275-81. PubMed ID: 7663381
[TBL] [Abstract][Full Text] [Related]
16. Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.
Banga HS; Simons ER; Brass LF; Rittenhouse SE
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9197-201. PubMed ID: 3024170
[TBL] [Abstract][Full Text] [Related]
17. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
Praticò D; Smyth EM; Violi F; FitzGerald GA
J Biol Chem; 1996 Jun; 271(25):14916-24. PubMed ID: 8663015
[TBL] [Abstract][Full Text] [Related]
18. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
20. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
